Nanjing First Hospital, Nanjing Medical University: Diabetes Mellitus, Type 2 trials

The registry lists 21 Diabetes Mellitus, Type 2 studies with Nanjing First Hospital, Nanjing Medical University as lead sponsor. 4 are open to participants now and 1 have results posted.

Phase 3 3Phase 4 6No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）RecruitingNCT06912321
• Current Status of Islet Alpha Cell Function in Patients with Type 2 DiabetesRecruitingNCT06825182Phase 3
• The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes MellitusNot yet recruitingNCT06182852
• Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 DiabetesRecruitingNCT05553093Phase 4
• Lipoprotein-associated Phospholipase A2 in Patients With Type 2 DiabetesCompletedNCT03362112Results posted
• The Progress of Diabetes After Supaglutide Treatment in Type 2 Diabetes PatientsStatus unknownNCT06605287
• Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 DiabetesStatus unknownNCT05856578Phase 4
• The Alteration of Gut Microbiota and Analysis of Related Factors in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownNCT05752851
• Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownNCT05629806Phase 3
• Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 DiabetesStatus unknownNCT05591235Phase 3
• The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin TherapyStatus unknownNCT05578352Not applicable
• Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and AcarboseCompletedNCT05035849Not applicable
• Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes MellitusCompletedNCT04847219Not applicable
• Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes MellitusStatus unknownNCT04120623Phase 4
• Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet SyringeStatus unknownNCT04093284Not applicable
• The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With GlargineStatus unknownNCT03659383Phase 4
• Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes MellitusStatus unknownNCT03631121Phase 4
• The Blood Glucose Control in Patients With Type 2 Diabetes Treated With GlargineStatus unknownNCT03566472
• Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 DiabetesCompletedNCT03519529
• Influence of Injection Technique of Premixed Insulin on Glucose Excursion in Type 2 Diabetes MellitusStatus unknownNCT03513055Not applicable
• Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 DiabetesCompletedNCT03226210Phase 4